期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Ability of human umbilical cord mesenchymal stem cells to repair chemotherapy-induced premature ovarian failure 被引量:24
1
作者 Jian Shen dai cao Jing-Li Sun 《World Journal of Stem Cells》 SCIE CAS 2020年第4期277-287,共11页
BACKGROUND Premature ovarian insufficiency(POI)and premature ovarian failure(POF)have become one of the major problems threatening women of childbearing age.Studies have shown that stem cells transplanted from bone ma... BACKGROUND Premature ovarian insufficiency(POI)and premature ovarian failure(POF)have become one of the major problems threatening women of childbearing age.Studies have shown that stem cells transplanted from bone marrow,umbilical cord,peripheral blood and amniotic fluid can migrate and proliferate to the ovary,promote ovarian function repair,increase the number of follicles and granulosa cells at all levels of ovary,improve endocrine function,and can differentiate into oocytes in specific ovarian environment to restore fertility to some extent.AIM To study the ability of human umbilical cord mesenchymal stem cells(hUCMSCs)to repair ovarian injury after chemotherapy.METHODS A total of 110 female BALB/c mice(aged 7-8 wk old)with body masses of 16.0-20.0 g were selected.The mice were fed until 12 wk of age,and cyclophosphamide was administered by intraperitoneal injection for 14 consecutive days to induce premature ovarian failure in mice.Seventy-five mice with estrous cycle disorder were screened and randomly divided into 3 groups according to their body weight:model group,positive control group and hUCMSC group,and each group had 25 mice.Another 25 mice were used as negative controls.The mice in the hUCMSC group were injected with hUCMSCs in the tail vein,and the mice in the positive control group were given an oestradiol valerate solution and a medroxyprogesterone acetate solution in the tail vein.On the 1^st,15^th,30^th,45^th,and 60^th days after intravenous administration,vaginal smears were made to monitor the estrous cycles of the mice.The ovaries were weighed,and pathological sections were made to observe the morphology of the follicles;blood samples were collected to monitor the concentration of sex hormones(oestradiol and follicle-stimulating hormone).RESULTS The estrous cycles of the model group mice were disrupted throughout the experiment.Mice in the hUCMSC group and the positive control group resumed normal estrous cycles.The ovarian weight of the model group mice continued to decline.The ovarian weight of the hUCMSC group mice and the positive control group mice decreased first and then gradually increased,and the ovarian weight of the hUCMSC group mice was heavier than that of the positive control group mice.The difference was statistically significant(P<0.05).Compared with the negative control group,the model group experienced a decrease in oestradiol and an increase in follicle-stimulating hormone,and the difference was statistically significant(P<0.05).Compared with the model group,the hUCMSC and positive control groups experienced a slight increase in oestradiol and a decrease in follicle-stimulating hormone;the difference was statistically significant(P<0.05).The pathological examination revealed that the mouse ovaries from the model group were atrophied,the volume was reduced,the cortical and medullary structures were disordered,the number of follicles at all stages was significantly reduced,the number of atretic follicles increased,the number of primordial follicles and corpus luteum significantly decreased,and the corpus luteum had an irregular shape.Compared with those of the model group,the lesions of the hUCMSC and positive control groups significantly improved.CONCLUSION hUCMSCs can repair ovarian tissue damaged by chemotherapy to a certain extent,can improve the degree of apoptosis in ovarian tissue,and can improve the endocrine function of mouse ovaries. 展开更多
关键词 UMBILICAL cord mesenchymal stem cells PREMATURE OVARIAN failure CHEMOTHERAPY REPAIR OVARIAN injury ENDOCRINE function
下载PDF
基于PSM比较TACE联合射频消融与单纯射频消融治疗小肝癌疗效
2
作者 孟泓宇 卢逸 +4 位作者 曹彦龙 戴操 杨佳伟 林楠 徐见亮 《中华肝脏外科手术学电子杂志》 CAS 2023年第4期417-421,共5页
目的探讨TACE联合射频消融(RFA)与单纯RFA两种方案治疗小肝癌(肿瘤数目≤3个,最大直径≤3 cm)的生存预后差异。方法回顾性分析2011年3月至2014年12月在中山大学附属第三医院接受TACE+RFA或RFA治疗的182例小肝癌患者临床资料。患者均签... 目的探讨TACE联合射频消融(RFA)与单纯RFA两种方案治疗小肝癌(肿瘤数目≤3个,最大直径≤3 cm)的生存预后差异。方法回顾性分析2011年3月至2014年12月在中山大学附属第三医院接受TACE+RFA或RFA治疗的182例小肝癌患者临床资料。患者均签署知情同意书,符合医学伦理学规定。其中男153例,女29例;年龄26~80岁,中位年龄53岁;肿瘤平均直径(20±6)mm;肝功能Child-Pugh分级A级153例,B级29例。根据治疗方案不同将患者分为TACE+RFA组(48例)和RFA组(134例)。观察两组围手术期并发症及生存情况。采用倾向性评分匹配(PSM)控制混杂因素影响。生存分析采用Kaplan-Meier法和Log-rank检验。结果两组经1∶1配对PSM匹配后各40例,TACE+RFA组术后发生胸腔积液1例;RFA组术后发生胸腔积液2例,胆漏1例;两组均无针道种植转移、大出血、肝衰竭、死亡等严重并发症发生。TACE+RFA组术后1、3、5年总体生存率分别为100%、97.5%、82.5%,RFA组相应为97.5%、90.0%、82.5%,两组术后总体生存率比较差异无统计学意义(χ^(2)=0.083,P=0.774)。TACE+RFA组术后1、3、5年无进展生存率分别为80.0%、60.0%、50.0%,RFA组相应为85.0%、64.3%、50.7%,两组术后无进展生存率比较差异无统计学意义(χ^(2)=0.406,P=0.524)。结论相较单纯RFA治疗,TACE联合RFA治疗小肝癌并不能提高患者术后生存。 展开更多
关键词 肝细胞 化学栓塞 治疗性 射频消融 生存分析 预后 倾向性评分匹配
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部